Health Hope Pharma ("HHP") is a US & HK-registered oncology pharmaceutical company principally engaged in the development of novel oral anti-cancer drugs.
Optimizing chemotherapy to improve treatment outcomes
Many chemotherapies are P-gp substrates, and can only be given intravenously
- Selective and very potent P-gp inhibitor
- Minimal systemic bioavailability
Encequidar is designed to allow for oral absorption of chemotherapy agents such as paclitaxel.
- Minimal systemic absorption
- Localized P-gp inhibitory activity in GI tract
- No significant systemic side effects to other organs & cells seen in clinical studies
- Expect lower incidence of severe toxicities associated with IV intravenous infusion